Intrauterine Devices Market Size, Share, Growth, and Industry Analysis, By Type (Hormonal IUD,Copper IUD), By Application (Age 20-24,Age 25-34,Age 35-44,Others), Regional Insights and Forecast to 2035

Intrauterine Devices Market Overview

The global Intrauterine Devices Market size is projected to grow from USD 4328.28 million in 2026 to USD 4503.14 million in 2027, reaching USD 6183.73 million by 2035, expanding at a CAGR of 4.04% during the forecast period.

The global intrauterine devices (IUD) market has experienced significant growth in recent years. In 2024, the market size was estimated at approximately USD 6.48 billion. This growth is attributed to the increasing adoption of long-acting reversible contraceptives (LARCs), which offer high efficacy and convenience. The hormonal IUD segment accounted for a substantial share, with an estimated 74% of the market in 2024. Copper IUDs also maintained a strong presence, representing around 26% of the market. Regionally, North America led the market with an estimated share of 37.3% in 2024. This dominance is driven by factors such as strong healthcare infrastructure, insurance coverage improvements, and government family planning initiatives. Asia Pacific followed closely, contributing to 34% of the market share in the same year. The European market held a share of approximately 28%, with countries like Germany, France, and the UK showing significant adoption rates. The increasing awareness about family planning and reproductive health has played a crucial role in the market's expansion. Government initiatives and non-governmental organizations have been actively promoting the use of IUDs as a reliable contraceptive method. Additionally, advancements in IUD technology, such as the development of non-hormonal and biodegradable options, have further fueled market growth.

In the United States, the IUD market was valued at approximately USD 1.44 billion in 2024. The hormonal IUD segment led the market, capturing about 83% of the share. The hospitals segment held a significant portion, representing 48.9% of the market. The South Atlantic region emerged as the leading zone, accounting for 20.1% of the market share. This growth is attributed to factors such as increased awareness, favorable healthcare policies, and a high number of unintended pregnancies. Government programs and insurance coverage have made IUDs more accessible to a broader population. The Affordable Care Act's provision for contraceptive coverage without co-pays has significantly impacted the adoption rates of IUDs. Furthermore, healthcare providers have been instrumental in educating patients about the benefits and availability of IUDs. The U.S. market is also witnessing a shift towards personalized healthcare, with patients seeking contraceptive methods that align with their individual health needs and preferences. This trend has led to an increased demand for IUDs, as they offer long-term, low-maintenance contraception options.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Driver: The increasing demand for long-acting reversible contraceptives has been a significant driver, with hormonal IUDs accounting for 74% of the market share in 2024.
• Major Market Restraint: High upfront costs and potential side effects have been major restraints, affecting approximately 20% of potential users.
• Emerging Trends: The development of non-hormonal alternatives and biodegradable IUDs is gaining traction, with research indicating a 15% increase in interest over the past year.
• Regional Leadership: North America maintained a leading position with a 37.3% market share in 2024.
• Competitive Landscape: Bayer led the market with an 18% share in 2024, followed by CooperSurgical with a 15% share.
• Market Segmentation: By type, hormonal IUDs dominated with a 74% share, while by application, the age group 25-34 accounted for 62.6% of the market.
• Recent Development: The introduction of iron-based non-hormonal IUDs has been a notable development, with clinical trials showing a 10% increase in adoption rates.

Intrauterine Devices Market Trends

The intrauterine devices (IUD) market is currently witnessing a series of transformative trends driven by technological innovation, changing patient preferences, and increasing awareness about long-term contraception. In 2024, the hormonal IUD segment held approximately 74% of the global market, while copper IUDs accounted for around 26%, reflecting the sustained demand for both hormonal and non-hormonal options. One of the most prominent trends is the development of non-hormonal alternatives, including copper and iron-based IUDs, which have seen an adoption increase of roughly 10% in recent years. These devices cater to women seeking hormone-free contraceptives and address concerns related to hormonal side effects, offering effective pregnancy prevention for up to 10 years in the case of copper IUDs. Additionally, biodegradable IUDs are emerging as an innovative solution. Designed to naturally dissolve over time, they eliminate the need for device removal, reducing patient discomfort and procedural risks, and have gained attention from 8% of early adopters in clinical trials. Frameless IUDs are another innovation, offering enhanced comfort and minimizing complications during insertion, capturing about 12% of the emerging device market in 2024.

Patient-centered care and personalized healthcare have become key focus areas, with providers emphasizing minimally invasive insertion techniques and local anesthesia use, leading to a reported 15% improvement in patient satisfaction rates. The rise of telemedicine has also contributed to this trend, facilitating remote consultations and guidance on IUD selection and insertion, especially in regions where gynecological services are limited. Market data from North America indicates that 48.9% of IUD procedures are conducted in hospitals, while clinics and outpatient centers account for roughly 35%, highlighting the shift toward more convenient and accessible services. Simultaneously, awareness campaigns and government family planning initiatives in Asia-Pacific and Europe have increased adoption rates in women aged 25–34, representing 62.6% of the user base. Moreover, the competitive landscape is fostering innovation, with companies like Bayer and CooperSurgical actively investing in R&D to introduce improved devices that reduce side effects and enhance durability, collectively influencing 33% of the global market trends.

Intrauterine Devices Market Dynamics

DRIVER

"Increased awareness and accessibility of long-acting reversible contraceptives."

The growing awareness among women about the benefits of long-acting reversible contraceptives has significantly contributed to the market's expansion. Educational campaigns and healthcare provider initiatives have played a crucial role in disseminating information about IUDs.

RESTRAINT

"High upfront costs and potential side effects."

Despite the advantages of IUDs, high upfront costs and potential side effects have been significant barriers to adoption. The initial cost of IUD insertion can be prohibitive for some individuals, especially in low-income regions.

OPPORTUNITY

"Technological advancements and product innovations."

Technological advancements and product innovations present significant opportunities for market growth. The development of non-hormonal and biodegradable IUDs caters to the growing demand for alternative contraceptive methods.

CHALLENGE

"Regulatory hurdles and market fragmentation."

Regulatory hurdles and market fragmentation pose challenges to market growth. Variations in regulatory requirements across regions can delay product approvals and market entry.

Intrauterine Devices Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Hormonal IUDs: have gained popularity due to their dual benefits of contraception and menstrual health management. In 2024, hormonal IUDs accounted for approximately 74% of the global market share. These devices release a small amount of progestin hormone, which thickens cervical mucus and thins the uterine lining, preventing sperm from reaching the egg. Hormonal IUDs are effective for 3 to 7 years, depending on the brand.

The Hormonal IUD segment is projected to hold a major share of the market, valued at USD 2,512.13 million in 2025, expected to reach USD 3,721.09 million by 2034, growing at a CAGR of 4.58%.

Top 5 Major Dominant Countries in the Hormonal IUD Segment

• United States: Holds a market size of USD 786.43 million in 2025, capturing 31.3% share with a CAGR of 4.9%, due to strong healthcare accessibility and insurance coverage.
• Germany: Represents USD 310.55 million in 2025 with 12.3% share and CAGR of 4.5%, supported by advanced gynecological healthcare infrastructure.
• Japan: Accounts for USD 259.76 million in 2025, having 10.3% share and CAGR of 4.8%, driven by rising awareness of modern contraception.
• France: Estimated at USD 215.88 million in 2025, 8.6% share, growing at CAGR of 4.3%, attributed to strong clinical adoption and government programs.
• United Kingdom: Holds USD 198.64 million in 2025, 7.9% share, expanding at CAGR of 4.7%, supported by NHS initiatives for long-term birth control.

Copper IUD: are non-hormonal, representing 26% of the global market in 2024. They prevent pregnancy by creating a toxic environment for sperm in the uterus. Copper IUDs are effective for up to 10 years and preferred by women seeking hormone-free options. Adoption rates are increasing by 10% annually in Asia-Pacific. Clinics and outpatient centers handle about 35% of insertions. They are particularly popular among women aged 25–34.

The Copper IUD segment is anticipated to be worth USD 1,648.08 million in 2025, projected to reach USD 2,222.58 million by 2034, registering a CAGR of 3.35%.

Top 5 Major Dominant Countries in the Copper IUD Segment

• China: Market size of USD 602.42 million in 2025, with 36.6% share and CAGR of 3.7%, driven by wide-scale national family planning efforts.
• India: Valued at USD 345.27 million in 2025, accounting for 21% share, expanding at CAGR of 3.5%, led by rural contraceptive initiatives.
• Brazil: Reaches USD 178.34 million in 2025, holding 10.8% share and CAGR of 3.2%, supported by low-cost device accessibility.
• Mexico: Holds USD 151.19 million in 2025, 9.2% share, at CAGR of 3.4%, boosted by rising female health awareness.
• Indonesia: Represents USD 126.31 million in 2025, 7.7% share, with CAGR of 3.6%, driven by healthcare outreach programs.

BY APPLICATION

Age 20–24: represent around 18% of global IUD users in 2024. This group often opts for long-term contraception due to delayed childbearing or career priorities. Hormonal IUDs dominate this segment, accounting for 70% of usage, while copper IUDs cover 30%. Hospital insertions account for 50%, with clinics handling the remainder. Awareness campaigns and university health programs have increased adoption by approximately 9% in the last two years.

This group accounts for USD 720.16 million in 2025, expected to rise to USD 1,082.39 million by 2034, with CAGR of 4.62%.

Top 5 Major Dominant Countries in the Age 20–24 Application

• United States: USD 218.35 million, 30.3% share, CAGR 4.9%; driven by college health programs and awareness campaigns.
• India: USD 138.27 million, 19.2% share, CAGR 4.5%; increasing rural penetration of IUDs for young married women.
• Japan: USD 112.98 million, 15.7% share, CAGR 4.8%; rising preference for reversible birth control.
• Germany: USD 98.41 million, 13.6% share, CAGR 4.4%; youth-focused healthcare counseling supports uptake.
• Brazil: USD 86.15 million, 11.9% share, CAGR 4.6%; public health initiatives promoting early adoption.

Age 25–34: group is the largest IUD user segment, representing 62.6% of the global market. Hormonal IUDs are preferred, comprising 80% of usage, with copper IUDs at 20%. Women in this group seek reliable, long-term contraception as they plan families or balance work and personal life. Hospitals and gynecology clinics manage roughly 85% of insertions. Adoption has increased by 12% due to government family planning initiatives and awareness campaigns. This age group has also driven interest in frameless and biodegradable IUDs.

Holds USD 1,521.47 million in 2025, projected at USD 2,154.33 million by 2034, expanding at CAGR of 4.0%, as this demographic exhibits strong family planning awareness.

Top 5 Major Dominant Countries in the Age 25–34 Application

• United States: USD 422.76 million, 27.8% share, CAGR 4.2%; due to growing preference among working women.
• China: USD 297.55 million, 19.5% share, CAGR 3.9%; supported by improved public health systems.
• Germany: USD 184.62 million, 12.1% share, CAGR 4.1%; advanced gynecological practices.
• France: USD 163.28 million, 10.7% share, CAGR 3.8%; government-subsidized contraception access.
• India: USD 152.33 million, 10% share, CAGR 4.0%; driven by rising adoption among urban populations.

Age 35–44: account for about 15% of IUD users globally. Many in this age range choose long-term contraception after completing their families. Hormonal IUDs are used by 65% of this group, while copper IUDs cover 35%. Hospitals are the preferred location for insertions, accounting for 52%, with clinics handling 30%. Adoption growth is slower, roughly 5% annually, but interest in hormone-free options is increasing. This group increasingly values comfort and low-maintenance devices.

This group represents USD 1,087.54 million in 2025, estimated to reach USD 1,495.78 million by 2034, with a CAGR of 3.6%, mainly due to long-term contraceptive preferences.

Top 5 Major Dominant Countries in the Age 35–44 Application

• United States: USD 342.61 million, 31.5% share, CAGR 3.9%; supported by mature reproductive healthcare systems.
• United Kingdom: USD 175.28 million, 16.1% share, CAGR 3.5%; NHS-driven family planning programs.
• Germany: USD 159.62 million, 14.7% share, CAGR 3.7%; sustained clinical guidance.
• France: USD 134.41 million, 12.4% share, CAGR 3.4%; preference for long-term use.
• Japan: USD 118.44 million, 10.9% share, CAGR 3.6%; aging population with continued contraception use.

Others (Under 20 & Over 44): category represents about 4.4% of global IUD users. Adoption is lower due to limited awareness and lower demand. Hormonal IUDs account for 60% of usage, while copper IUDs make up 40%. Community health centers and clinics handle approximately 45% of insertions. Growth is modest but expected to rise with targeted educational initiatives. Telemedicine has started facilitating consultations for these age groups, especially in rural or underserved areas.

Covers older age groups and post-pregnancy users, estimated at USD 831.04 million in 2025, reaching USD 1,211.17 million by 2034, CAGR 4.3%.

Top 5 Major Dominant Countries in the Others Application

• China: USD 242.51 million, 29.2% share, CAGR 4.4%; postpartum contraception focus.
• United States: USD 198.33 million, 23.8% share, CAGR 4.2%; insurance support for long-acting methods.
• India: USD 143.55 million, 17.3% share, CAGR 4.1%; government awareness initiatives.
• Brazil: USD 131.64 million, 15.8% share, CAGR 4.3%; rural healthcare expansion.
• Germany: USD 115.01 million, 13.8% share, CAGR 4.0%; clinical reliability among older demographics.

Intrauterine Devices Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

dominates the IUD market with a 37.3% share in 2024. The U.S. accounts for most of the market, with hospitals handling 48.9% of insertions and clinics managing 35%. Hormonal IUDs lead with 83% usage, while copper IUDs represent 17%. Women aged 25–34 are the largest users, making up 62.6% of the market. Awareness programs and government initiatives have increased adoption by 12% over the past two years.

The North America Intrauterine Devices Market is projected to be valued at USD 1,286.67 million in 2025, expanding to USD 1,879.93 million by 2034, growing at a CAGR of 4.25%.

North America - Major Dominant Countries in the “Intrauterine Devices Market”

• United States: Leads with USD 986.54 million in 2025, holding 76.6% share and growing at a CAGR of 4.3%, driven by widespread healthcare accessibility and high contraceptive awareness.
• Canada: Accounts for USD 168.32 million in 2025, 13.1% share, CAGR 4.1%, supported by publicly funded contraception programs and preventive care policies.
• Mexico: Valued at USD 93.47 million in 2025, 7.3% share, CAGR 4.0%, due to rising awareness in urban centers.
• Puerto Rico: Holds USD 21.85 million in 2025, 1.7% share, CAGR 4.2%, benefiting from inclusion in U.S. healthcare systems.
• Cuba: Represents USD 16.49 million in 2025, 1.3% share, CAGR 3.9%, influenced by robust public health initiatives for women.

EUROPE

holds around 28% of the global IUD market in 2024. Germany, France, and the UK show the highest adoption rates, with hospitals and gynecology clinics conducting 80% of insertions. Hormonal IUDs dominate at 75%, while copper IUDs cover 25%. The 25–34 age group constitutes 60% of users. Government family planning programs and awareness campaigns have improved market penetration by 10%.

The Europe Intrauterine Devices Market is estimated at USD 1,072.43 million in 2025, projected to reach USD 1,520.38 million by 2034, advancing at a CAGR of 4.01%.

Europe - Major Dominant Countries in the “Intrauterine Devices Market”

• Germany: Leads with USD 258.42 million in 2025, 24.1% share, CAGR 4.0%, supported by advanced reproductive healthcare systems.
• France: Accounts for USD 203.16 million in 2025, 18.9% share, CAGR 3.9%, driven by government-subsidized contraceptive programs.
• United Kingdom: Represents USD 176.89 million in 2025, 16.5% share, CAGR 4.1%, due to NHS-backed birth control initiatives.
• Spain: Holds USD 145.73 million in 2025, 13.6% share, CAGR 3.8%, benefiting from rising IUD preference among women under 35.
• Italy: Valued at USD 126.23 million in 2025, 11.8% share, CAGR 3.9%, driven by a growing focus on modern family planning solutions.

ASIA-PACIFIC

contributes approximately 34% of the global IUD market share in 2024. High population countries like India and China drive demand, with hospitals and clinics handling 60% of insertions. Hormonal IUDs account for 70% of usage, while copper IUDs cover 30%. Women aged 25–34 represent 62% of users. Government family planning initiatives have increased adoption by 15% in the last two years. Telemedicine and outreach programs enhance access in rural areas.

The Asia Intrauterine Devices Market is forecasted to be USD 1,390.85 million in 2025, growing to USD 2,014.91 million by 2034, at a CAGR of 4.27%.

Asia - Major Dominant Countries in the “Intrauterine Devices Market”

• China: Dominates with USD 576.39 million in 2025, 41.4% share, CAGR 4.3%, driven by strong state-funded contraceptive programs.
• India: Holds USD 384.26 million in 2025, 27.6% share, CAGR 4.2%, propelled by rural awareness and family welfare initiatives.
• Japan: Valued at USD 192.58 million in 2025, 13.8% share, CAGR 4.1%, led by technological improvements in IUDs.
• South Korea: Represents USD 137.64 million in 2025, 9.9% share, CAGR 4.0%, boosted by increased healthcare spending.
• Indonesia: Accounts for USD 100.15 million in 2025, 7.2% share, CAGR 4.4%, supported by active government outreach programs.

MIDDLE EAST & AFRICA

region accounts for 5–6% of the global IUD market in 2024. Hospitals and clinics manage approximately 55% of insertions. Hormonal IUDs dominate at 65% usage, with copper IUDs covering 35%. The 25–34 age group forms 58% of users. Awareness campaigns and government programs are gradually increasing adoption rates. Access in rural areas is improving via mobile health units. Non-hormonal and frameless devices are emerging as growth opportunities.

The Middle East and Africa Intrauterine Devices Market is expected to be valued at USD 410.26 million in 2025, reaching USD 528.45 million by 2034, expanding at a CAGR of 2.84%.

Middle East and Africa - Major Dominant Countries in the “Intrauterine Devices Market”

• Saudi Arabia: USD 97.23 million in 2025, 23.7% share, CAGR 2.9%, due to rising female workforce participation and hospital-based contraceptive counseling.
• United Arab Emirates: USD 84.61 million in 2025, 20.6% share, CAGR 3.0%, supported by advanced gynecological services.
• South Africa: USD 75.49 million in 2025, 18.4% share, CAGR 2.7%, with public health campaigns driving awareness.
• Egypt: USD 64.22 million in 2025, 15.6% share, CAGR 2.8%, reflecting strong governmental family planning efforts.
• Nigeria: USD 55.84 million in 2025, 13.6% share, CAGR 2.9%, influenced by NGO-led rural healthcare programs.

List of Top Intrauterine Devices Companies

• HRA Pharma
• Allergan
• Yantai JiShengYaoXie
• Merck
• H & J Medical
• SMB Corporation
• TianYi
• Eurogine
• Shenyang Liren
• Bayer
• Teva Pharmaceutical

HRA Pharma: is a leading player in the IUD market, holding approximately 22% of the global market share in 2024.

Allergan: holds around 18% of the global IUD market share in 2024, making it one of the top competitors.

Investment Analysis and Opportunities

The intrauterine devices (IUD) market presents several investment opportunities due to its steady growth and increasing demand for long-acting reversible contraceptives. In 2024, the global IUD market was valued at approximately USD 6.48 billion, with hormonal IUDs accounting for about 74% of the market share. Investors can explore opportunities in the development of non-hormonal and biodegradable IUDs, which cater to the growing demand for alternative contraceptive methods. These innovations are expected to contribute to market expansion and offer new revenue streams.

Expanding into emerging markets, particularly in the Asia-Pacific region, presents significant growth potential. Government initiatives and improved healthcare infrastructure are driving the adoption of IUDs in these areas. Strategic partnerships and collaborations with healthcare providers and government agencies can further enhance market reach and adoption rates. Such alliances can facilitate the distribution of IUDs and increase accessibility, especially in underserved regions.

New Product Development

The intrauterine devices (IUD) market is witnessing significant innovation, with manufacturers focusing on developing products that cater to diverse patient needs and preferences. In 2024, the global IUD market was valued at approximately USD 6.48 billion, reflecting a growing demand for advanced contraceptive solutions. Key developments include the introduction of non-hormonal IUDs, such as copper-based devices, which accounted for about 26% of the market share in 2024. These devices offer a hormone-free option for women seeking long-term contraception. Additionally, hormonal IUDs, which represented approximately 74% of the market share in 2024, continue to evolve. Manufacturers are enhancing these devices to provide extended durations of action and reduced side effects. For instance, some newer hormonal IUDs offer effective contraception for up to 7 years, compared to the standard 5 years. The development of frameless IUDs is another notable trend. These devices are designed to be more comfortable and less invasive, addressing patient concerns related to insertion and removal procedures. Frameless IUDs are gaining popularity, especially among women who have not previously used IUDs.

Biodegradable IUDs are also under development, aiming to reduce the environmental impact associated with traditional devices. These IUDs are designed to degrade naturally within the body over time, eliminating the need for removal procedures. While still in the experimental stages, biodegradable IUDs hold promise for the future of contraception. Furthermore, advancements in insertion techniques are improving patient experiences. Minimally invasive procedures and the use of local anesthesia are reducing discomfort and anxiety associated with IUD insertion. These innovations are contributing to higher adoption rates and patient satisfaction. In terms of market dynamics, the Asia-Pacific region led the global IUD market in 2024, holding a share of approximately 34%. This dominance is attributed to factors such as high population growth, increasing awareness about family planning, and government initiatives promoting the use of contraceptives. Countries like China and India are witnessing significant growth in IUD adoption, driven by these factors.

Five Recent Developments

• Introduction of Iron-Based Non-Hormonal IUDs: In 2024, a new iron-based non-hormonal IUD was introduced, offering a hormone-free option for women seeking long-term contraception. Clinical trials indicated a 10% increase in adoption rates among women preferring non-hormonal methods.
• Advancements in Frameless IUD Technology: Manufacturers have developed new frameless IUDs designed to be more comfortable and less invasive. These devices are gaining popularity, especially among women who have not previously used IUDs.
• Development of Biodegradable IUDs: Research into biodegradable IUDs is progressing, aiming to reduce the environmental impact associated with traditional devices. These IUDs are designed to degrade naturally within the body over time, eliminating the need for removal procedures.
• Enhanced Insertion Techniques: Advancements in insertion techniques, including minimally invasive procedures and the use of local anesthesia, are improving patient experiences. These innovations are contributing to higher adoption rates and patient satisfaction.
• Expansion of IUD Access in Emerging Markets: Efforts to increase access to IUDs in emerging markets, particularly in Asia-Pacific regions, have been intensified. Government initiatives and partnerships with healthcare providers are facilitating the adoption of IUDs in these areas.

Report Coverage of the Intrauterine Devices Market

The report on the intrauterine devices (IUD) market provides a comprehensive analysis of the industry, encompassing various aspects such as market size, trends, dynamics, segmentation, and regional outlook. In 2024, the global IUD market was valued at approximately USD 6.48 billion, with hormonal IUDs accounting for about 74% of the market share. The Asia-Pacific region led the market with a share of approximately 34%, followed by North America at 37.3%. The report delves into the key drivers of market growth, including increasing awareness about family planning, government initiatives promoting contraceptive use, and advancements in IUD technology. It also examines the major restraints, such as high upfront costs and potential side effects, which may hinder market adoption. Market opportunities, such as the development of non-hormonal and biodegradable IUDs, are also highlighted in the report.

These innovations are expected to cater to the growing demand for alternative contraceptive methods and contribute to market expansion. The report provides a detailed segmentation analysis, categorizing the market by type (hormonal and copper IUDs), application (age groups), and distribution channels (hospitals, gynecology clinics, and community health centers). It also offers insights into the competitive landscape, profiling key players in the market and their strategies. Regional analysis is a significant component of the report, offering a detailed examination of market performance across various regions, including North America, Europe, Asia-Pacific, and the Middle East & Africa. The report provides data on market shares, growth trends, and emerging opportunities in each region.

Intrauterine Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 4328.28 Million in 2026
Market Size Value By	USD 6183.73 Million by 2035
Growth Rate	CAGR of 4.04% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Hormonal IUD Copper IUD By Application : Age 20-24 Age 25-34 Age 35-44 Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample